Atirix Medical Systems, Inc. – Trademark Portfolio

Entity Type: 03

Atirix Medical Systems, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 5 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include ATIRIX and QC-TRACK. The owner is based in Minnetonka, MN.

10201 Wayzata Blvd, Suite 310

Minnetonka, MN 55305

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

ATIRIX
ATIRIX
Registered 2021
ATIRIX
ATIRIX
Cancelled 2009
QC-TRACK
QC-TRACK
Registered 2009
MOM
MOM
Cancelled 2008

Trademark Classifications

Atirix Medical Systems, Inc.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

9
Computers & Electronics (5 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does Atirix Medical Systems, Inc. have?

Atirix Medical Systems, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 2 cancelled.

What trademark classes does Atirix Medical Systems, Inc. file in?

Atirix Medical Systems, Inc. files trademarks across 1 Nice Classification class. The most active classes are Class 9 (Computers & Electronics). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.

What are Atirix Medical Systems, Inc.'s most well-known trademarks?

Atirix Medical Systems, Inc.'s registered trademark portfolio includes well-known marks such as ATIRIX and QC-TRACK. These are among 2 currently registered trademarks in the portfolio.

What is Atirix Medical Systems, Inc.'s trademark registration success rate?

Atirix Medical Systems, Inc. has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.